Background Vaping rates are increasing globally. Restricting vaping products’ access may result in net population health loss if youths who vape switch to smoking, or net gain if it promotes cessation ...

The loss of the pharmacies is part of an ongoing national sell-off of all Rite Aid assets. It’s also part of a familiar trend in the area and other rural communities in the country, as both ...

Patient-reported outcomes could have a prognostic and predictive impact on care for multiple myeloma.A retrospective analysis ...

Horizon Government Affairs has merged with private equity-backed Monument Advocacy to build out a healthcare policy shop the ...

Senior Services is seeking a volunteer receptionist for the Generations Center on Mondays and Fridays. Both morning and afternoon shifts are available. Volunteers will answer incoming calls, direct ...

The Indian agency Narcotics Control Bureau, which functions under the Ministry of Home Affairs (MHA), played a pivotal role in a global anti-drug operation, "Operation Med Max" that was launched in ...

People of a certain age may remember Merthiolate and Mercurochrome in the household medicine chest. Whenever someone skinned a knee or scraped an elbow, one of these topical antiseptics was often ...

In the past, if you had a question or curiosity about global norms, you'd probably talk it over with friends, family, or ...

Cybin has made steady progress but faces major hurdles, with its stock swayed by sector sentiment. Read why CYBN stock is ...

Pharmacist job demand rose notably in the first quarter of 2025, with a total of 20,053 pharmacist job postings recorded between January and March, up from 18,896 during the same period in 2024, ...

Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

The FDA has approved a label update for Eli Lilly’s Kisunla, an Alzheimer’s treatment, by modifying the recommended dosing schedule for adults with early symptomatic Alzheimer’s disease. The update ...